Pharmaceutical Industry Articles & Reports - Page 28

Learn how Large Language Models (LLMs) like GPT-5.4 and RAG pipelines are used for financial document analysis. Updated for 2026 with benchmarks, SEC AI disclosure rules, and agentic workflows for extracting insights from SEC filings and corporate decks.

An in-depth guide for bench scientists on using LLM copilots in research. Covers GPT-5.2, Gemini 2.5 Pro, Benchling AI, DeepMind co-scientist, real-world performance data, FDA guidance, and 2026 adoption trends.

Understand algorithmic redlining, a form of AI bias creating housing and lending discrimination. Explore its causes, legal frameworks including the EU AI Act and state enforcement, and effective technical solutions. Updated with 2025-2026 enforcement actions, CFPB changes, and Colorado AI Act developments.

Learn why spreadsheets fail for life sciences contract management. This guide explores how AI-powered CLM platforms — including agentic AI tools like Icertis Vera — improve efficiency, compliance, and clinical trial cycle times. Updated for 2026 with EU AI Act enforcement, FDA/EMA joint AI principles, and the latest Gartner Magic Quadrant CLM leaders.

Compare per-token API costs: Grok from $0.20/M, Gemini $1.25/M, GPT-4o $5/M, Claude Opus $15/M. Updated pricing tables and enterprise plans.

An educational overview of the NeurIPS 2025 conference. Learn about key trends in AI research, including LLMs, major awards, acceptance rates, and new paper tra

Every Claude plan compared: Free, Pro $20, Max $100-$200, Team, Enterprise, plus per-token API costs for Opus, Sonnet, Haiku. Updated for 2026.

A complete guide to Google Gemini for business plans and pricing (updated April 2026). Learn about Gemini 3.1 Pro, AI Pro/Ultra subscriptions, API costs, Workspace tiers, enterprise models, and real-world use cases.

Oracle's $300B, 5-year cloud deal with OpenAI: 4.5 GW/year of compute, the live Abilene campus, and Oracle's $523B contract backlog as of 2026.

Analysis of OpenAI's ChatGPT ads strategy — now live since February 2026. Covers the financial data, 900M+ weekly users, $25B revenue, Go tier, IPO plans & AI monetization

Learn about Causaly Pipeline Graph and Agentic Research, AI platforms integrating competitive intelligence and knowledge graphs for pharma R&D. Updated April 2026 with market data, FDA guidance, and platform evolution.

Learn about Clarivate Cortellis, the life sciences intelligence platform for drug discovery and R&D. Updated for 2026 with AI assistant launch and Claude MCP integration.

An in-depth 2026 review of the AlphaSense market intelligence platform. Learn how its AI search, Generative Grid, Financial Data, and Workflow Agents work, plus user reviews, $500M ARR growth, and competitive analysis.

An in-depth analysis of the Los Angeles biotech industry (updated April 2026). Covers ~4,000 life science companies, $60B+ economic output, Amgen's $600M expansion, Capsida's IND clearances, UCLA Research Park, and NIH funding developments shaping LA's ecosystem

An in-depth review of top AlphaSense alternatives for market research in 2026. Compare features & use cases of Bloomberg, FactSet, PitchBook, Klue, and expert networks

Updated 2026 guide to the Veeva Direct Data API. Covers features, open-source accelerators for Snowflake/Databricks/Redshift, 26R1 Vault Time changes, AI Agents integration, and bulk data extraction for analytics and AI on Veeva Vault data.

Explore the Boston-Cambridge biotech ecosystem in 2026. This guide covers top companies like Biogen, Vertex & Moderna, venture funding trends, federal policy impacts, and Massachusetts' drug development pipeline.

Explore San Diego's biotech hub, a top 3 U.S. cluster. Updated for 2026 with $4.8B VC funding data, NIH funding crisis impact, major acquisitions (Avidity $12B, Poseida $1.5B), and company updates for Illumina, Neurocrine, Halozyme

Learn how AI and machine learning analyze Real-World Data (RWD) to generate Real-World Evidence (RWE). Explore key applications including LLM-driven data extraction, pharmacovigilance, and synthetic control arms, plus 2025-2026 FDA and EMA regulatory updates.

Explore a data-driven analysis of AI's impact on the 2025 job market for recent graduates. Learn about declining entry-level jobs and new skill demands.

A technical review of Gemini Nano Banana Pro and Nano Banana 2, Google’s AI image models. Learn key specs, pricing, 1M-token context, and applications in life sciences

Explore practical applications of Claude Code in life sciences. This guide covers its use in genomics, bioinformatics, and R&D automation via tool connectors. L

A data-driven analysis of the 2025 Clinical Research Associate (CRA) job market, covering global demand, salary benchmarks, turnover rates, and career outlook.

Learn best practices for eDiary data collection in clinical trials. Updated for 2026 with ICH E6(R3), FDA DCT guidance, AI integration, and eCOA vendor landscape changes.